KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
基本信息
- 批准号:2900706
- 负责人:
- 金额:$ 21.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-08-01 至 2002-03-31
- 项目状态:已结题
- 来源:
- 关键词:G protein autocrine biological signal transduction bradykinin caveolas cytokine fluorescence microscopy genetic promoter element hormone receptor hormone regulation /control mechanism inflammation kinins laboratory rabbit receptor binding receptor coupling receptor expression receptor sensitivity tissue /cell culture vascular smooth muscle
项目摘要
DESCRIPTION (Adapated from Investigator's Abstract): This grant is
requested to support an ongoing program in basic research aimed at
understanding the structural basis and molecular mechanisms underlying the
function and regulation of receptors for vasoactive peptides. For this
purpose, the P.I. will use the kinin receptor system as a model. Kinins,
pro-inflammatory peptides released extracellularly following injury, act
through two distinct receptors, B1 and B2, which both belong to the seven
transmembrane-domain, G-protein-coupled receptor (GPCR) superfamily. The B2
receptor mediates the actions of bradykinin (BK), whereas the B1 receptor
mediates the actions of the carboxypeptidase product des-Arg9BK. The
physiological responses to kinins include vasodilatation, smooth muscle
spasm, edema, hyperalgesia, pain, modulation of hormone and cytokine
release, increased epithelial transport, and cell proliferation. Based on
these properties, kinins have been implicated in a number of
pathophysiological processes involving injury, inflammation, and healing.
In order to understand regulation of peptide action in health and disease, a
comprehensive research program with two intimately linked goals focusing on
kinin receptors has been developed: 1) to study mechanisms of short-term
regulation of B1 and B2 receptors by receptor agonists including
desensitization and internalization, and 2) to study mechanisms of long-term
regulation of B1 and B2 receptor expression by autocrine mechanisms through
receptor agonists and by other factors involved in injury and inflammation.
The combined study of B1 and B2 receptors also offers unique opportunities
to identify structural requirements in peptide GPCR as the ligands and
effectors for these receptors are similar while the receptors themselves
show relatively little sequence homology. The goals of the research program
will be achieved using established techniques from several disciplines
including molecular biology, protein chemistry, and cellular imaging of
fluoroprobes. This research program will increase our understanding of the
regulation of kinin action in pathophysiological states such as
inflammation, and will in turn, provide significant insights into general
mechanisms of action and regulation of vasoactive peptides.
描述(改编自研究者摘要):该补助金是
要求支持正在进行的基础研究计划,
了解其结构基础和分子机制,
血管活性肽受体的功能和调节。 为此
目的私家侦探将使用激肽受体系统作为模型。 激肽,
损伤后细胞外释放的促炎肽,
通过两种不同的受体,B1和B2,它们都属于七个
跨膜结构域,G蛋白偶联受体(GPCR)超家族。 的b2
受体介导缓激肽(BK)的作用,而B1受体
介导羧肽酶产物des-Arg9BK的作用。 的
对激肽的生理反应包括血管舒张、平滑肌
痉挛、水肿、痛觉过敏、疼痛、激素和细胞因子调节
释放,增加上皮转运和细胞增殖。 基于
由于这些性质,激肽已经涉及许多
涉及损伤、炎症和愈合的病理生理过程。
为了了解肽在健康和疾病中的作用,
综合研究计划,有两个密切相关的目标,重点是
激肽受体已经被开发出来:1)研究短期的机制,
通过受体激动剂调节B1和B2受体,包括
脱敏和内化,2)研究长期的机制,
通过自分泌机制调节B1和B2受体表达,
受体激动剂和其他参与损伤和炎症的因素。
B1和B2受体的联合研究也提供了独特的机会
鉴定肽GPCR作为配体的结构要求,
这些受体的效应物是相似的,而受体本身
显示出相对较少的序列同源性。 研究计划的目标
将使用几个学科的既定技术来实现
包括分子生物学、蛋白质化学和细胞成像,
荧光探针。 这项研究计划将增加我们对
调节激肽在病理生理状态下的作用,
炎症,并将反过来,提供重要的见解,一般
血管活性肽的作用和调节机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fredrik L.M. Leeb-Lundberg其他文献
Fredrik L.M. Leeb-Lundberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fredrik L.M. Leeb-Lundberg', 18)}}的其他基金
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
2180990 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
2180992 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
6385902 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
6180462 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
2637515 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
3467555 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
3467554 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
3467553 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
3467552 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
KININ RECEPTORS--MOLECULAR PROPERTIES AND REGULATION
激肽受体——分子特性和调控
- 批准号:
3467551 - 财政年份:1988
- 资助金额:
$ 21.86万 - 项目类别:
相似海外基金
Paracrine and autocrine IL-6 as drivers of treatment resistance in medulloblastoma
旁分泌和自分泌 IL-6 作为髓母细胞瘤治疗抵抗的驱动因素
- 批准号:
468060 - 财政年份:2022
- 资助金额:
$ 21.86万 - 项目类别:
Operating Grants
Targeting Autocrine Hepatocyte Growth Factor (HGF) Production as a Therapeutic Modality in Acute Myeloid Leukemia (AML)
靶向自分泌肝细胞生长因子 (HGF) 的产生作为急性髓系白血病 (AML) 的治疗方式
- 批准号:
10589002 - 财政年份:2022
- 资助金额:
$ 21.86万 - 项目类别:
Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneys
自分泌和旁分泌足细胞信号会降低老年肾脏的肾小球功能/健康
- 批准号:
10698100 - 财政年份:2022
- 资助金额:
$ 21.86万 - 项目类别:
Elucidating the role of autocrine TNF signaling in maintaining human regulatory T cell identity
阐明自分泌 TNF 信号传导在维持人类调节性 T 细胞身份中的作用
- 批准号:
BB/W001055/1 - 财政年份:2022
- 资助金额:
$ 21.86万 - 项目类别:
Research Grant
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10615236 - 财政年份:2021
- 资助金额:
$ 21.86万 - 项目类别:
Rôle autocrine des exosomes sécrétés par le muscle dans un contexte de diabète de type 2
2 型糖尿病背景下肌肉中外泌体的自分泌作用
- 批准号:
466812 - 财政年份:2021
- 资助金额:
$ 21.86万 - 项目类别:
Studentship Programs
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10296083 - 财政年份:2021
- 资助金额:
$ 21.86万 - 项目类别:
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10469480 - 财政年份:2021
- 资助金额:
$ 21.86万 - 项目类别:
Mitochondrial reactive oxygen species act as autocrine neuromodulators in retinal ganglion cells
线粒体活性氧在视网膜神经节细胞中充当自分泌神经调节剂
- 批准号:
10157645 - 财政年份:2021
- 资助金额:
$ 21.86万 - 项目类别:
Mitochondrial reactive oxygen species act as autocrine neuromodulators in retinal ganglion cells
线粒体活性氧在视网膜神经节细胞中充当自分泌神经调节剂
- 批准号:
10343744 - 财政年份:2021
- 资助金额:
$ 21.86万 - 项目类别: